Kyphoscoliosis peptidase (KY) mutation causes a novel congenital myopathy with core targetoid defects

  • Acta Neuropathol. 2016 Sep;132(3):475-8. doi: 10.1007/s00401-016-1602-9.
Rachel Straussberg  1 Gudrun Schottmann  2 Menachem Sadeh  3 Esther Gill  2 Franziska Seifert  2 Ayelet Halevy  1 Kaiyal Qassem  1 John Rendu  4 Peter F M van der Ven  5 Werner Stenzel  6 Markus Schuelke  7  8
Affiliations
  • 1. Neurology Institute, Schneider Children's Medical Center of Israel and Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel.
  • 2. Department of Neuropediatrics and NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • 3. Department of Neurology, Wolfson Medical Center, Holon, Israel.
  • 4. Biochimie Génétique et Moléculaire, Département de Biochimie Toxicologie et Pharmacologie Centre Hospitalier Universitaire Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
  • 5. Department of Molecular Cell Biology, Institute for Cell Biology, University of Bonn, Bonn, Germany.
  • 6. Institute of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • 7. Department of Neuropediatrics and NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. [email protected].
  • 8. Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. [email protected].